Filing Details
- Accession Number:
- 0001127602-17-031892
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-13 16:00:24
- Reporting Period:
- 2017-11-09
- Accepted Time:
- 2017-11-13 16:00:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1014739 | Bioscrip Inc. | BIOS | Services-Home Health Care Services (8082) | 050489664 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1704288 | Stephen Deitsch | C/O Bioscrip, Inc. 1600 Broadway, Suite 700 Denver CO 80202 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.0001 Par Value | Acquisiton | 2017-11-09 | 10,000 | $2.03 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $.0001 Par Value | Restricted Stock Unit | Acquisiton | 2017-11-09 | 35,211 | $0.00 | 35,211 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
35,211 | 2018-11-09 | 2018-11-12 | No | 4 | A | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- Each Restricted Stock Unit represents a right to receive one share of Common Stock upon vesting. Vesting occurs one year from the date of grant.